ArticleMMWR. Morbidity and mortality weekly report2021
Decreases in Young Children Who Received Blood Lead Level Testing During COVID-19 - 34 Jurisdictions, January-May 2020.
Article in MMWR. Morbidity and mortality weekly report, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- A community-based participatory research program to identify lead exposure risks and community priorities.Discover social science and health · 2026Article
- COVID-19 and Completion of Select Routine Childhood Vaccinations.Pediatrics · 2025Article
- Reductions in Blood Lead Level Screening During Peak COVID-19 Restrictions and Beyond.Public health challenges · 2025Article
- Impact of the COVID-19 Pandemic on Childhood Lead Testing and Blood Lead Levels.Academic pediatrics · 2024Article
- Impact of the COVID-19 Pandemic on Blood Lead Testing in Children in the United States.Population health management · 2024Article
- Identifying High-Risk ZIP Codes for Childhood Lead Exposure: A Statewide ZCTA-Level Priority List for North Carolina.North Carolina medical journal · 2024Article
- Who tests for lead and why? A 10-year analysis of blood lead screening, follow-up and CNS outcomes in a statewide US healthcare system.Occupational and environmental medicine · 2024Article
- Notes from the Field: COVID-19 Pandemic-Related Changes in Blood Lead Screening - Chicago, Illinois, 2017-2022.MMWR. Morbidity and mortality weekly report · 2023Article
- Matrix-matched calibrators are necessary for robust and high-quality dried blood spots lead screening assays by inductively coupled plasma-mass spectrometry.Journal of mass spectrometry and advances in the clinical lab · 2023Article
- Effect of the COVID-19 Global Pandemic on Illinois Children Tested for Blood Lead Level and Exposure.American journal of public health · 2023Article
- Exposure Sources Among Veterans With Elevated Blood Lead Levels, United States, 2015‒2021.American journal of public health · 2022Article
- Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children.Infectious disease clinics of North America · 2022Review
- Missed routine pediatric care and vaccinations in US children during the first year of the COVID-19 pandemic.Preventive medicine · 2022Article
- Primary care and COVID - Opportunities abound.Current problems in pediatric and adolescent health care · 2022Article
- Effect of COVID-19 Pandemic on Well Child Care and Vaccination.Frontiers in pediatrics · 2022Article
- Tuberculosis - United States, 2020.MMWR. Morbidity and mortality weekly report · 2021Article
- Improving Adherence to the Lead Exposure Protocol at Boston Medical Center's Pediatric Clinic.Pediatric quality & safetyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exposure to lead, a toxic metal, can result in severe effects in children, including decreased ability to learn, permanent neurologic damage, organ failure, and death. CDC and other health care organizations recommend routine blood lead level (BLL) testing among children as part of well-child examinations to facilitate prompt identification of elevated BLL, eliminate source exposure, and provide medical and other services (1). To describe BLL testing trends among young children during the coronavirus disease 2019 (COVID-19) pandemic, CDC analyzed data reported from 34 state and local health departments about BLL testing among children aged <6 years conducted during January-May 2019 and January-May 2020. Compared with testing in 2019, testing during January-May 2020 decreased by 34%, with 480,172 fewer children tested. An estimated 9,603 children with elevated BLL were missed because of decreased BLL testing. Despite geographic variability, all health departments reported fewer children tested for BLL after the national COVID-19 emergency declaration (March-May 2020). In addition, health departments reported difficulty conducting medical follow-up and environmental investigations for children with elevated BLLs because of staffing shortages and constraints on home visits associated with the pandemic. Providers and public health agencies need to take action to ensure that children who missed their scheduled blood lead screening test, or who required follow-up on an earlier high BLL, be tested as soon as possible and receive appropriate care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.